
Tanib 400mg Tablet
Marketer
Winx Medihaat Innovations Private Limited
Salt Composition
Imatinib mesylate (400mg)
Overview Tanib 400mg Tablet
Nivolumab 400mg tablets are indicated for various cancers. Primary uses include blood cancers (chronic myeloid leukemia and acute lymphoblastic leukemia) and gastrointestinal stromal tumors. Its mechanism involves targeting specific proteins crucial for cancer cell proliferation and metastasis. It's also employed in dermatofibrosarcoma protuberans and aggressive systemic mastocytosis. Administer this medication with food, consistently at the same time daily for optimal efficacy. Continue treatment as directed by your physician; duration depends on individual response. Improper dosage can result in serious adverse effects. Therapeutic benefits may not be apparent for weeks or months; discontinue only under medical supervision. Common side effects include swelling, nausea, vomiting, muscle spasms, musculoskeletal pain, diarrhea, skin rash, tiredness, and stomach pain. Report any unexpected, rapid weight gain. Regular blood count and liver function monitoring may be advised. Refrain from driving or mentally demanding tasks if dizziness or blurred vision occur. Inform your healthcare provider about all concurrent medications due to potential interactions. This medication is contraindicated during pregnancy and breastfeeding; reliable contraception for both partners is essential throughout treatment.
Uses of Tanib 400mg Tablet
Cancer Therapy
Major Benefits of Tanib 400mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 400mg Tanib tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
Common Side effects of Tanib 400mg Tablet:
- Edema (swelling)
- Nausea
- Vomiting
- Muscle cramp
- Musculoskeletal (bone, muscle or joint) pain
- Diarrhea
- Rash
- Fatigue
- Abdominal pain
- Bleeding
- Breathing problems
- Cough
- Weight gain
- Dry eye
- Dizziness
- Hemorrhage
How to use Tanib 400mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 400mg Tanib Tablet should be administered with a meal.
How Tanib 400mg Tablet works:
Tanib 400mg tablets combat cancer by targeting the bcr-abl tyrosine kinase enzyme. This protein fuels the uncontrolled growth of cancerous cells. The drug blocks this enzyme's activity, halting cancerous cell multiplication and triggering their programmed self-destruction in bcr-abl positive cancers, thus controlling or slowing disease progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Tanib 400mg Tablets may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Use of Tanib 400mg tablets is contraindicated during pregnancy due to established risk to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Tanib 400mg Tablet during breastfeeding is likely unsafe. Available human data indicates potential transfer to breast milk, posing a risk to the infant. Breastfeeding should be discontinued while taking this medication and for a period of 15 days following cessation.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Tanib 400mg Tablets.
KidneyCAUTION
Individuals with kidney impairment should exercise caution when using Tanib 400mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tanib 400mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Tanib 400mg Tablet :
Omit any missed Tanib 400mg Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Tanib 400mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzanilide Derivative |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Active Class | Tyrosine kinase inhibitor drugs |
